Navigation Links
New Study Provides Scientific Evidence That DermaLastyl Face Cream Reduces Wrinkles
Date:11/5/2007

Before And After Measurements Using Laser Profilometry Prove Wrinkle

Cream's Efficacy

NEW YORK, Nov. 5 /PRNewswire/ -- DermaPlus, Inc., makers of DermaLastyl anti-aging skin creams, announced today the preliminary results of their 12-week clinical trial on the anti-aging effects of its skin creams. Renowned, anti-aging doctor, Dr. Steven Lamm, oversaw the study, in which 35 volunteers were imaged by a sophisticated technique called laser profilometry before and after using DermaLastyl for 12 weeks. The profilometry data and digital photographs were analyzed by computers to compare a series of parameters such as roughness, length and depth of wrinkles. The study results showed significant improvements in all parameters: 83% of the participants showed significant improvement in skin smoothness and reduction in the appearance of fines lines and wrinkles. (Study results provided upon request.)

The key ingredient in DermaLastyl products is Elastatropin, a synthetic form of natural elastin. Elastin, the second most abundant protein in the body, is responsible for the elasticity of skin and organs, and its degradation is a well-known irreversible cause of wrinkles. DermaLastyl is revolutionary because it is the first cosmetic product ever to contain a complete functional human protein. DermaPlus synthesized the human Tropoelastin gene and uses this DNA to laboratory manufacture its own Elastatropin brand of human elastin. The study now provides unequivocal proof that topical application of DermaLastyl reduces the appearance of current wrinkles, and helps prevent the formation of new ones.

Noted microbiologist Dr. Burt Ensley, CEO of DermaPlus, Inc., said: "After introducing our products, we were challenged in news reports by Dr. Amy Neuberger and Dr. Lamm to provide objective evidence to support our claims, especially since most skin cream vendors advertise the results of consumer self-evaluation studies that are co
'/>"/>

SOURCE DermaPlus, Inc.
Copyright©2007 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ovementShownforthe4thStraightYear ,, WASHINGT...erAlliance-Georgia(LCA-GA)issuedthe 4thAnnualRepor...essbeingmadeagainstthislethaldiseaseinthestateofGe...eonlynationalorganizationdedicatedexclusivelytopat...orlungcancer. ,, (Logo: http://www.newscom.com/...
(Date:11/25/2009)...at colorectal cancer also can reverse a rare stoma...erapy for the disease, researchers at Vanderbilt U...ier,s disease causes thickening of the stomach lin...s well as anemia and swelling in the feet and ankl...risk for gastric cancer. Previously, the only effe...
(Date:11/25/2009)...d under the skin kill tumor cells, study finds , ...A cancer vaccine delivered in a fingernail-size im...udy reports. , The method uses polymer disks, 8...umor-specific antigens and implanted under the ski... The Harvard University scientists who developed t...
(Date:11/25/2009)... Nationwide Imaging Services, known as one of...iagnostic imaging equipment, now offering a total ...cing options, service and installation with acquis...echnologies of California) , ...ide Imaging Services is proud to announce its acqu...
(Date:11/25/2009)... BioSpace.com, the premier resource for life ...d edition of the BioForest™ Hotbed Campaign ..., CO (Vocus) November 25, 2009 -- BioSpace.com, th...formation, unveiled the third edition of the BioFo...,This regional campaign is a promotional effort hi...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
...travenous antiviral drug may be helpful in easing ... which is caused by varicella-zoster virus, is a p...ports that researchers at the University of Colora...ts received 10 milligrams of the drug acyclovir in...
... a high degree of comfort level in ethnically dive...re safer// , and make the students feel wanted. St...ared to other schools. Psychologists from UCLA ...rity of low-income students who belong to the mino...
...f food poisoning, now has a new remedy, which is s... working at the University of Bristol//. The fin...esearchers have narrowed down on a particular anti...ed for the treatment of listeriosis, in spite of i...
...d that there is a need for more talking therapies ... has planned to announce the sites of two talking ...ed at cognitive behavioural therapy (CBT) in help...ts helpline callers show 83% take medication while...
...ties seem to eat healthy food compared to their pe...//. Teenage girls who participate in weight-re...stics and wrestling are more likely to eat breakfa...r team sports. The results of this present study c...
...red by scientists at UCSF, Celera Genomics and The...reased risk// for early heart attack, or myocardia...VAMP8, normally expresses a protein essential for ...ack risk can help identify people at risk and clar...
Other Medicine News:Health News:Comfort Level, Maximum in Ethnically Diverse Schools 2Health News:Comfort Level, Maximum in Ethnically Diverse Schools 3Health News:Gene Variants Linked to Early Heart Attack Discovered 2Health News:Gene Variants Linked to Early Heart Attack Discovered 3Health News:Gene Variants Linked to Early Heart Attack Discovered 4
(Date:11/25/2009)...e/-- ChemoCentryx,Inc.,announcedtodaythatPhaseII/...ctiveRandomizedOralTherapyEvaluationinCrohn,sdisea...oderate-to-severeCrohn,sdiseasedemonstratedclinica...e.Thestudydemonstratedevidenceofclinicalefficacyin...ecreaseintheCrohn,sDiseaseActivityIndex(CDAI)inpat...
(Date:11/24/2009)..., WHAT:RomHoubens,aBelgianmanthoughttohavebeeninco...lyconsciousandawakeduringthattimeandwasthesubjecto...turedinthesegmenttoillustratehowpeoplewithLocked-i... ,, WHEN:GoodMorningAmerica-- Tuesday,November2..., WHO:RomHoubenswasanengineeringstudentin1986when...
(Date:11/24/2009)...Call/--QuestDiagnosticsIncorporated(NYSE: DGX ),th...tionandservices,announcedthatitisscheduledtospeaka...wYorkCity.ThepresentationisscheduledforWednesday,D...econference,thecompanywillreaffirmits2009guidancef...ceed18%ofrevenues,anddilutedearningspersharefromco...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 1 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 2 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 3 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 4 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 5 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 6AlphaHelix Presents AmpXpress 28TM 29 at the BIOTECHNICA Show 14356 1AlphaHelix Presents AmpXpress 28TM 29 at the BIOTECHNICA Show 14356 2US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 1US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 2US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 3
...orporation (Nasdaq:,DNDN) today will present a sum...uleucel-T), an investigational active cellular imm...um in New York City. The presentation, which,integ...s the safety,profile, immune response and clinical...sitive cancer who have failed standard therapy., ...
...Pharmaceuticals,Inc. (Nasdaq: VIAP ), a biotechno...ds for the treatment of cardiovascular disease, an...and webcast to discuss results of the,VIA-2291 Pha...arterectomy,(CEA) trials presented at the American...on Sunday, November 9. The conference call and web...
Other Medicine Technology:Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 2Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 3Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 4VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA 2
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
Medicine Products: